drugset / Trial / NCT00057434

Vitamin A Therapy for Tuberculosis

NCT00057434 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The study will determine whether a daily vitamin and mineral supplement (a multivitamin including Vitamin A) will improve health when added to standard chemotherapy for tuberculosis. This study will compare the effectiveness of the multivitamin in HIV infected and HIV uninfected patients.

Timeline

Start
1998-09
Primary completion
—
Completion
—

Outcome

Missed primary endpoint

paper Micronutrient supplementation did not reduce mortality (hazard ratio [HR] 0.93, 95%CI 0.75-1.15) among HIV-positive adults. PMID 17705950 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Multivitamin Other / unclassified — —